Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures
Joanna H Cox1 Stefano Seri2,3 Andrea E Cavanna1,2,4,51College of Medical and Dental Sciences, University of Birmingham, 2School of Life and Health Sciences, Aston Brain Centre, Aston University, 3Children’s Epilepsy Surgery Programme, The Birmingham Children’s Hospital...
Guardado en:
Autores principales: | Cox JH, Seri S, Cavanna AE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc4863352836406f9e7c40c3127f6a77 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Misophonia: current perspectives
por: Cavanna AE, et al.
Publicado: (2015) -
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg JLZ, et al.
Publicado: (2011) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
por: Leahy JT, et al.
Publicado: (2011) -
Lack of progression of beta dynamics after long‐term subthalamic neurostimulation
por: Ross W. Anderson, et al.
Publicado: (2021) -
Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
por: Zaccara G, et al.
Publicado: (2021)